INCTR UPDATE
59 CANCER CONTROL 2021
Individuals, institutions or organizations often choose to serve
as Associate Members who contribute financially to the work of
INCTR.
What does INCTR do?
INCTR addresses all aspects of cancer control with the overall
goal of lessening the morbidity and mortality from cancer. It
emphasizes training and education of healthcare professionals
in LMICs to ensure that "best practices" are instilled in cancer
prevention, early diagnosis, treatment and palliative care.
Research is an integral part of its work with its partners in LMICs
in order to accurately document the cancer burden - including the
types of cancer and extent of disease, the outcomes of prevention
and early detection campaigns and the efficacy, toxicity and cost
of treatment delivered. It also emphasizes public awareness
of cancer, which is an essential component of early diagnosis.
INCTR has a variety of programmes that are carried out in close
collaboration with its branches as well as its partner institutions in
developing countries. INCTR's current programmes include:
J adult oncology; J cancer registry;
J clinical research; J foundational;
J palliative care; J paediatric oncology;
J pathology.
INCTR's projects and achievements
Each INCTR programme has goals and objectives in line with the
overall mission of the organization, divided into separate projects.
Many projects have been conducted or are on-going and include:
Adult oncology
J Prevention, early diagnosis, and treatment of selected cancers
in poor urban areas and in rural and tribal regions in the state
of Rajasthan in India.
J Cervical cancer screening using visual inspection in Nepal and
Tanzania.
J Training of Bolivian healthcare professionals in cervical cancer
screening by Peruvian experts.
J HPV vaccination of young girls in Nepal.
Cancer registries
J Establishing an East African Registry Network (EARN) that
0 5 10 15 20 25 30 35 40 45
30
25
20
15
10
5
0
% of global workforce
Size of the dots is proportional to total health expenditure% of global burden of disease
Western Pacific
Europe
Americas
Africa
South-East Asia
Eastern Mediterranean
(Source: WHO, 2006)
Distribution of health workers by level of health expenditure
and burden of disease, WHO regions
66
8000000
) (16.4.2012)
4161941
) (16.4.2012)
000 4500000 5000000
nternet].
an.iarc.fr Accessed: 8 March 2013.
den of cancer in 2008:
80(9856):1840-50.
2008 total incident cases 7.1 million
2030 total incident cases 12.7 million
World
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages)
World
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages) - Both sexes
Male
Female
11471506
9790012
0 2000000 4000000 6000000 8000000 10000000 12000000 14000000
(Source: GLOBOCAN 2008 (IARC) (19.3.2013)
21261518
(Source: GLOBOCAN 2008 (IARC) (19.3.2013)
0 5000000 10000000 15000000 20000000 25000000
■ Incidence in 2008 ■ Demographic effect
■ Incidence in 2008 ■ Demographic effect
Adapted with permission from:
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.
GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].
Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Accessed: 8 March 2013.
Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008:
a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.
Figure 1: Disease burden and resources
STRATEGIES
J To build capacity for cancer prevention, diagnosis, treatment
and palliation through professional education and training
J To conduct, or provide materials for the conduct of educational
campaigns for the public and primary care doctors about the
causes of cancer and living a healthier life
J To work with experts in-country to conduct locally relevant
research on cancer control
2008 total incident cases 7.1 million
2030 total incident cases 12.7 million
Less developed regions
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages)
2008 total incident cases 2.3 million
2030 total incident cases 7.4 million
0 5 10 15 20 25 30 35 40 45
30
25
20
15
10
5
0
% of global workforce
Size of the dots is proportional to total health expenditure% of global burden of disease
Western Pacific
Europe
Americas
Africa
South-East Asia
Eastern Mediterranean
(Source: WHO, 2006)
Distribution of health workers by level of health expenditure
and burden of disease, WHO regions
More developed regions
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages)
Male
Female
6733466
6053193
0 1000000 2000000 3000000 4000000 5000000 6000000 7000000 8000000
(Source: GLOBOCAN 2008 (IARC) (16.4.2012)
Male
Female
4161941
3263670
(Source: GLOBOCAN 2008 (IARC) (16.4.2012)
0 500000 1000000 1500000 2000000 2500000 3000000 3500000 4000000 4500000 5000000
■ Incidence in 2008 ■ Demographic effect
■ Incidence in 2008 ■ Demographic effect
Founder and
active members
Associate members
Advisory Board
Branches
Programmes
Clinical research
Pathology
Paediatric oncology
Cancer registry
Oncology nursing
Foundational
Palliative care
Governing Council
Executive Committee
Committees
Ethical
review
OERC
consortium Funding
Disease-specific
startegy groups Adapted with permission from:
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.
GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet].
Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr Accessed: 8 March 2013.
Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of cancer in 2008:
a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(9856):1840-50.
2008 total incident cases 7.1 million
2030 total incident cases 12.7 million
World
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages)
World
All cancers excl. non-melanoma skin cancer
Number of new cancers in 2030 (all ages) - Both sexes
Male
Female
11471506
9790012
0 2000000 4000000 6000000 8000000 10000000 12000000 14000000
(Source: GLOBOCAN 2008 (IARC) (19.3
21261518
(Source: GLOBOCAN 2008 (IARC) (19.3
0 5000000 10000000 15000000 20000000 250000
■ Incidence in 2008 ■ Demographic effect
■ Incidence in 2008 ■ Demographic effect
Adapted with permission from:
Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM.
GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10 [Internet]
Lyon, France: International Agency for Research on Cancer; 2010. Available from: http://globocan.iarc.fr
Soerjomataram I, Lortet-Tieulent J, Parkin DM, Ferlay J, Mathers C, Forman D, Bray F. Global burden of c
a systematic analysis of disability-adjusted life-years in 12 world regions. Lancet. 2012 Nov 24;380(985
Figure 2: Disease burden and resources
to become familiar with the most pressing issues and to develop
plans to improve efficiency and reduce cost. Although clearly
many countries have limited health workforces and quantitation
of such workforces can be valuable in terms of planning for the
future, it realizes that many cancer plans have little impact
because of the limited resources and great difficulty in expanding
interventions to very poor populations which cannot "purchase"
their own healthcare needs and which have little or no chance of
expanding their present resources. Having a cancer plan is not
enough. Successful cancer plans require knowledge and a budget
in addition to educated health professionals.
INCTR's structure
INCTR has consultants and volunteers dedicated to the
accomplishment of its goals. Although its headquarters are
located in Brussels, it has branches in the United States, Canada,
Brazil, United Kingdom, France, Egypt, Nepal and India. Branches
are legally-established NGOs that contribute to and conduct
programmes and projects that are relevant to INCTR's mission.
Resource development, administration and programmes (e.g.,
adult oncology, paediatric oncology, cancer registries, pathology
and palliative care are supervised by an Executive Committee or
directly by the branches. The Executive Committee is responsible
to INCTR's Governing Council. Programmes and projects are
developed with the participation, input and advice of various
INCTR committees and strategy groups, as well as independent
scientific advisers. Programmes and projects are conducted
in collaboration with partner institutions involved with cancer
research, diagnosis and treatment, including palliative care and
education in countries with limited resources.